NASDAQ:ITRM
Iterum Therapeutics plc
- Stock
locale
Ireland
market
STOCKSindustry
Biotechnologywebsite
www.iterumtx.comipo date
May 25, 2018
Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract infections, complicated urinary trac...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus